 RattanIndia Power Ltd consolidated Q2FY26 loss at Rs. 31.55 crores
RattanIndia Power Ltd consolidated Q2FY26 loss at Rs. 31.55 crores Dr Lal Path Labs Ltd reports Rs. 150.6 crores consolidated profit in Q2 FY26
Dr Lal Path Labs Ltd reports Rs. 150.6 crores consolidated profit in Q2 FY26 Sammaan Capital Ltd consolidated Q2 FY2025-26 net profit at Rs. 308.47 crores
Sammaan Capital Ltd consolidated Q2 FY2025-26 net profit at Rs. 308.47 crores Aptus Value Housing Finance India Ltd Q2 FY2026 consolidated PAT higher at Rs. 226.54 crores
Aptus Value Housing Finance India Ltd Q2 FY2026 consolidated PAT higher at Rs. 226.54 crores Sigma Solve Ltd Q2 FY2026 consolidated profit up at Rs. 6.64 crores
Sigma Solve Ltd Q2 FY2026 consolidated profit up at Rs. 6.64 crores 
              A meeting of the Board of Directors of M/s. Vista Pharmaceuticals Limited will be held on Thursday, 13.04.2017 at 5:00 p.m. at the corporate office of the company at 7-1-212/A/70, 1st Floor, Plot No.85, Shivbagh, Ameerpet, Hyderabad - 500016, to consider the allotment of balance equity shares and convertible warrants to the promoters.
The Board will also consider any other business with the permission of the Chair.
Shares of VISTA PHARMACEUTICALS LTD. was last trading in BSE at Rs.45.8 as compared to the previous close of Rs. 44.85. The total number of shares traded during the day was 1243689 in over 1343 trades.
The stock hit an intraday high of Rs. 47.05 and intraday low of 43.05. The net turnover during the day was Rs. 57548777.